CLINICAL_TRIALS ClinicalTrials.gov record update

Sodium Risedronate 17.5 mg Tablets Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) - 48-week Surveillance -

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02106455
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:16.926238+00:00
Published At: 2019-06-03T00:00:00+00:00
Record Updated At: 2019-06-03
Results Posted At: 2019-06-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Osseous Paget\u0027s Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-06-03"
protocolSection.identificationModule.nctId: "NCT02106455"
protocolSection.identificationModule.officialTitle: "Sodium Risedronate 17.5 mg Tablets Special Drug Use Surveillance in Patients With Osseous Paget\u0027s Disease (All-case Surveillance) - 48-week Surveillance -"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2019-06-03"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.